Loading…

Looking for RET alterations in thyroid cancer: clinical relevance, methodology and timing

Purpose Thyroid carcinoma (TC) is a rare neoplasia of the endocrine system and account for about 2–3% of all human tumors. According to their cell origin and histological features, different histotypes of thyroid carcinoma are described. Genetic alterations involved in the pathogenesis of thyroid ca...

Full description

Saved in:
Bibliographic Details
Published in:Endocrine 2023-08, Vol.81 (2), p.206-215
Main Authors: Elisei, Rossella, Romei, Cristina
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c375t-8df3786c99c2d20e8473c65e49acc99bcab3742dd2b50af7a12db6d1fa7f78483
cites cdi_FETCH-LOGICAL-c375t-8df3786c99c2d20e8473c65e49acc99bcab3742dd2b50af7a12db6d1fa7f78483
container_end_page 215
container_issue 2
container_start_page 206
container_title Endocrine
container_volume 81
creator Elisei, Rossella
Romei, Cristina
description Purpose Thyroid carcinoma (TC) is a rare neoplasia of the endocrine system and account for about 2–3% of all human tumors. According to their cell origin and histological features, different histotypes of thyroid carcinoma are described. Genetic alterations involved in the pathogenesis of thyroid cancer have been described and it has been shown that alterations of the RET gene are common events in all TC hystotypes. Aim of this review is to give an overview of the relevance of RET alterations in TC and to provide indications, timing and methodologies, for RET genetic analysis. Methods A revision of the literature has been performed and indications for the experimental approach for the RET analysis have been reported. Conclusions The analysis of RET mutations in TC has a very important clinical relevance for the early diagnosis of the hereditary forms of MTC, for the follow-up of TC patients and for the identification of those cases that can benefit from a specific treatment able to inhibit the effect of mutated RET .
doi_str_mv 10.1007/s12020-023-03368-w
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2814814398</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2829811894</sourcerecordid><originalsourceid>FETCH-LOGICAL-c375t-8df3786c99c2d20e8473c65e49acc99bcab3742dd2b50af7a12db6d1fa7f78483</originalsourceid><addsrcrecordid>eNp9kMtKAzEUhoMoXqov4EICblw4msvMJONOxBsUBKkLVyGTZNroTFKTqaVvb2rrBRdCIOGc7_wnfAAcYnSGEWLnERNEUIYIzRClJc_mG2AXF0WVodTf_PXeAXsxviBECCnZNtihDFdFwfEueB56_2rdGDY-wMfrEZRtb4LsrXcRWgf7ySJ4q6GSTplwAVVrnVWyhcG05n1ZPIWd6Sde-9aPF1A6DXvbpcR9sNXINpqD9T0ATzfXo6u7bPhwe391OcwUZUWfcd1QxktVVYpoggzPGVVlYfJKqlSslawpy4nWpC6QbJjERNelxo1kDeM5pwNwssqdBv82M7EXnY3KtK10xs-iIBzn6dBqiR7_QV_8LLj0u0SRimPMqzxRZEWp4GMMphHTYDsZFgIjsRQvVuJFEi8-xYt5GjpaR8_qzujvkS_TCaArIKaWG5vws_uf2A-DhY6d</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2829811894</pqid></control><display><type>article</type><title>Looking for RET alterations in thyroid cancer: clinical relevance, methodology and timing</title><source>Springer Link</source><creator>Elisei, Rossella ; Romei, Cristina</creator><creatorcontrib>Elisei, Rossella ; Romei, Cristina</creatorcontrib><description>Purpose Thyroid carcinoma (TC) is a rare neoplasia of the endocrine system and account for about 2–3% of all human tumors. According to their cell origin and histological features, different histotypes of thyroid carcinoma are described. Genetic alterations involved in the pathogenesis of thyroid cancer have been described and it has been shown that alterations of the RET gene are common events in all TC hystotypes. Aim of this review is to give an overview of the relevance of RET alterations in TC and to provide indications, timing and methodologies, for RET genetic analysis. Methods A revision of the literature has been performed and indications for the experimental approach for the RET analysis have been reported. Conclusions The analysis of RET mutations in TC has a very important clinical relevance for the early diagnosis of the hereditary forms of MTC, for the follow-up of TC patients and for the identification of those cases that can benefit from a specific treatment able to inhibit the effect of mutated RET .</description><identifier>ISSN: 1559-0100</identifier><identifier>ISSN: 1355-008X</identifier><identifier>EISSN: 1559-0100</identifier><identifier>DOI: 10.1007/s12020-023-03368-w</identifier><identifier>PMID: 37195581</identifier><language>eng</language><publisher>New York: Springer US</publisher><subject>Carcinoma, Medullary ; Clinical Relevance ; Diabetes ; Endocrine system ; Endocrinology ; Genetic analysis ; Humanities and Social Sciences ; Humans ; Internal Medicine ; Medicine ; Medicine &amp; Public Health ; multidisciplinary ; Multiple Endocrine Neoplasia Type 2a ; Mutation ; Proto-Oncogene Mas ; Proto-Oncogene Proteins c-ret - genetics ; Ret protein ; Review ; Science ; Thyroid cancer ; Thyroid carcinoma ; Thyroid Neoplasms - diagnosis ; Thyroid Neoplasms - genetics</subject><ispartof>Endocrine, 2023-08, Vol.81 (2), p.206-215</ispartof><rights>The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature 2023. Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.</rights><rights>2023. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c375t-8df3786c99c2d20e8473c65e49acc99bcab3742dd2b50af7a12db6d1fa7f78483</citedby><cites>FETCH-LOGICAL-c375t-8df3786c99c2d20e8473c65e49acc99bcab3742dd2b50af7a12db6d1fa7f78483</cites><orcidid>0000-0002-5957-8902</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/37195581$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Elisei, Rossella</creatorcontrib><creatorcontrib>Romei, Cristina</creatorcontrib><title>Looking for RET alterations in thyroid cancer: clinical relevance, methodology and timing</title><title>Endocrine</title><addtitle>Endocrine</addtitle><addtitle>Endocrine</addtitle><description>Purpose Thyroid carcinoma (TC) is a rare neoplasia of the endocrine system and account for about 2–3% of all human tumors. According to their cell origin and histological features, different histotypes of thyroid carcinoma are described. Genetic alterations involved in the pathogenesis of thyroid cancer have been described and it has been shown that alterations of the RET gene are common events in all TC hystotypes. Aim of this review is to give an overview of the relevance of RET alterations in TC and to provide indications, timing and methodologies, for RET genetic analysis. Methods A revision of the literature has been performed and indications for the experimental approach for the RET analysis have been reported. Conclusions The analysis of RET mutations in TC has a very important clinical relevance for the early diagnosis of the hereditary forms of MTC, for the follow-up of TC patients and for the identification of those cases that can benefit from a specific treatment able to inhibit the effect of mutated RET .</description><subject>Carcinoma, Medullary</subject><subject>Clinical Relevance</subject><subject>Diabetes</subject><subject>Endocrine system</subject><subject>Endocrinology</subject><subject>Genetic analysis</subject><subject>Humanities and Social Sciences</subject><subject>Humans</subject><subject>Internal Medicine</subject><subject>Medicine</subject><subject>Medicine &amp; Public Health</subject><subject>multidisciplinary</subject><subject>Multiple Endocrine Neoplasia Type 2a</subject><subject>Mutation</subject><subject>Proto-Oncogene Mas</subject><subject>Proto-Oncogene Proteins c-ret - genetics</subject><subject>Ret protein</subject><subject>Review</subject><subject>Science</subject><subject>Thyroid cancer</subject><subject>Thyroid carcinoma</subject><subject>Thyroid Neoplasms - diagnosis</subject><subject>Thyroid Neoplasms - genetics</subject><issn>1559-0100</issn><issn>1355-008X</issn><issn>1559-0100</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2023</creationdate><recordtype>article</recordtype><recordid>eNp9kMtKAzEUhoMoXqov4EICblw4msvMJONOxBsUBKkLVyGTZNroTFKTqaVvb2rrBRdCIOGc7_wnfAAcYnSGEWLnERNEUIYIzRClJc_mG2AXF0WVodTf_PXeAXsxviBECCnZNtihDFdFwfEueB56_2rdGDY-wMfrEZRtb4LsrXcRWgf7ySJ4q6GSTplwAVVrnVWyhcG05n1ZPIWd6Sde-9aPF1A6DXvbpcR9sNXINpqD9T0ATzfXo6u7bPhwe391OcwUZUWfcd1QxktVVYpoggzPGVVlYfJKqlSslawpy4nWpC6QbJjERNelxo1kDeM5pwNwssqdBv82M7EXnY3KtK10xs-iIBzn6dBqiR7_QV_8LLj0u0SRimPMqzxRZEWp4GMMphHTYDsZFgIjsRQvVuJFEi8-xYt5GjpaR8_qzujvkS_TCaArIKaWG5vws_uf2A-DhY6d</recordid><startdate>20230801</startdate><enddate>20230801</enddate><creator>Elisei, Rossella</creator><creator>Romei, Cristina</creator><general>Springer US</general><general>Springer Nature B.V</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0002-5957-8902</orcidid></search><sort><creationdate>20230801</creationdate><title>Looking for RET alterations in thyroid cancer: clinical relevance, methodology and timing</title><author>Elisei, Rossella ; Romei, Cristina</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c375t-8df3786c99c2d20e8473c65e49acc99bcab3742dd2b50af7a12db6d1fa7f78483</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2023</creationdate><topic>Carcinoma, Medullary</topic><topic>Clinical Relevance</topic><topic>Diabetes</topic><topic>Endocrine system</topic><topic>Endocrinology</topic><topic>Genetic analysis</topic><topic>Humanities and Social Sciences</topic><topic>Humans</topic><topic>Internal Medicine</topic><topic>Medicine</topic><topic>Medicine &amp; Public Health</topic><topic>multidisciplinary</topic><topic>Multiple Endocrine Neoplasia Type 2a</topic><topic>Mutation</topic><topic>Proto-Oncogene Mas</topic><topic>Proto-Oncogene Proteins c-ret - genetics</topic><topic>Ret protein</topic><topic>Review</topic><topic>Science</topic><topic>Thyroid cancer</topic><topic>Thyroid carcinoma</topic><topic>Thyroid Neoplasms - diagnosis</topic><topic>Thyroid Neoplasms - genetics</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Elisei, Rossella</creatorcontrib><creatorcontrib>Romei, Cristina</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Endocrine</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Elisei, Rossella</au><au>Romei, Cristina</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Looking for RET alterations in thyroid cancer: clinical relevance, methodology and timing</atitle><jtitle>Endocrine</jtitle><stitle>Endocrine</stitle><addtitle>Endocrine</addtitle><date>2023-08-01</date><risdate>2023</risdate><volume>81</volume><issue>2</issue><spage>206</spage><epage>215</epage><pages>206-215</pages><issn>1559-0100</issn><issn>1355-008X</issn><eissn>1559-0100</eissn><abstract>Purpose Thyroid carcinoma (TC) is a rare neoplasia of the endocrine system and account for about 2–3% of all human tumors. According to their cell origin and histological features, different histotypes of thyroid carcinoma are described. Genetic alterations involved in the pathogenesis of thyroid cancer have been described and it has been shown that alterations of the RET gene are common events in all TC hystotypes. Aim of this review is to give an overview of the relevance of RET alterations in TC and to provide indications, timing and methodologies, for RET genetic analysis. Methods A revision of the literature has been performed and indications for the experimental approach for the RET analysis have been reported. Conclusions The analysis of RET mutations in TC has a very important clinical relevance for the early diagnosis of the hereditary forms of MTC, for the follow-up of TC patients and for the identification of those cases that can benefit from a specific treatment able to inhibit the effect of mutated RET .</abstract><cop>New York</cop><pub>Springer US</pub><pmid>37195581</pmid><doi>10.1007/s12020-023-03368-w</doi><tpages>10</tpages><orcidid>https://orcid.org/0000-0002-5957-8902</orcidid></addata></record>
fulltext fulltext
identifier ISSN: 1559-0100
ispartof Endocrine, 2023-08, Vol.81 (2), p.206-215
issn 1559-0100
1355-008X
1559-0100
language eng
recordid cdi_proquest_miscellaneous_2814814398
source Springer Link
subjects Carcinoma, Medullary
Clinical Relevance
Diabetes
Endocrine system
Endocrinology
Genetic analysis
Humanities and Social Sciences
Humans
Internal Medicine
Medicine
Medicine & Public Health
multidisciplinary
Multiple Endocrine Neoplasia Type 2a
Mutation
Proto-Oncogene Mas
Proto-Oncogene Proteins c-ret - genetics
Ret protein
Review
Science
Thyroid cancer
Thyroid carcinoma
Thyroid Neoplasms - diagnosis
Thyroid Neoplasms - genetics
title Looking for RET alterations in thyroid cancer: clinical relevance, methodology and timing
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-27T18%3A04%3A56IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Looking%20for%20RET%20alterations%20in%20thyroid%20cancer:%20clinical%20relevance,%20methodology%20and%20timing&rft.jtitle=Endocrine&rft.au=Elisei,%20Rossella&rft.date=2023-08-01&rft.volume=81&rft.issue=2&rft.spage=206&rft.epage=215&rft.pages=206-215&rft.issn=1559-0100&rft.eissn=1559-0100&rft_id=info:doi/10.1007/s12020-023-03368-w&rft_dat=%3Cproquest_cross%3E2829811894%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c375t-8df3786c99c2d20e8473c65e49acc99bcab3742dd2b50af7a12db6d1fa7f78483%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2829811894&rft_id=info:pmid/37195581&rfr_iscdi=true